0.61(2.69%) Volume: 538,654 7:08PM EST| Market Cap : 2.32 B | Enterprise Value : 1.91 B | P/E (TTM) : | P/B : 4.83 |
|---|
NAS:DNLI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:DNLI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
A company may raise cash from issuing new shares. It can also use cash to buy back shares.
Denali Therapeutics's net issuance of stock for the three months ended in Sep. 2019 was USD 0.0 Mil. The number is 0, which means that Denali Therapeutics has paid equal amouunt of cash to buy back shares to the amount it received for issuing shares quarterly.
Denali Therapeutics's net issuance of stock for the trailing twelve months (TTM) ended in Sep. 2019 was USD 0.0 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
| Denali Therapeutics Quarterly Data | |||||||||||||
| Dec15 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | |
| Net Issuance of Stock |
|
|
|
|
|
|
|
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.
Net Issuance of Stock for the trailing twelve months (TTM) ended in Sep. 2019 was 0 (Dec. 2018 ) + 0 (Mar. 2019 ) + 0 (Jun. 2019 ) + 0 (Sep. 2019 ) = USD 0.0 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline
Excel Add-In GURUF
API
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
My Gurus
Email Alerts
Stock PDF
RSS
Website
Filings
Manual of Stocks™ Web APP